
$93,000
Per-patient cost of Provenge, a new anti-cancer vaccine that has been shown to prolong life in prostate cancer patients by four months. On Wednesday, a federal committee offered support for the treatment, which makes it likelier that Medicare will cover its cost. [via Wall Street Journal]








